BioXcel Therapeutics, Inc. (BTAI)

NASDAQ: BTAI · IEX Real-Time Price · USD

2.57

-0.17 (-6.20%)

Sep 28, 2023, 10:15 AM EDT - Market open

Balance Sheet (Annual)

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2022	2021	2020	2019	2018	2017	2016
Cash & Equivalents	193.73	232.97	213.12	32.43	42.57	0.89	0
Cash & Cash Equivalents	193.73	232.97	213.12	32.43	42.57	0.89	0
Cash Growth	-16.84%	9.31%	557.25%	-23.82%	4698.76%	-	-
Receivables	0.25	0	0	0	0.12	0	0
Inventory	1.99	0	0	0	0	0	0
Other Current Assets	6.91	3.84	3.95	1.68	0.49	0	0
Total Current Assets	202.87	236.81	217.07	34.11	43.17	0.89	0
Property, Plant & Equipment	2.06	2.54	2.78	2.23	0.33	0	0.01
Other Long-Term Assets	0.93	0.09	0.09	0.05	0.05	0.46	0
Total Long-Term Assets	2.99	2.63	2.87	2.29	0.38	0.47	0.01
Total Assets	205.85	239.44	219.94	36.39	43.55	1.36	0.01
Accounts Payable	10.65	4.88	4.14	4.95	1.6	0.51	0.28
Current Debt	0	0	0	0	0	0.37	0
Other Current Liabilities	22.25	11.79	7.71	3.52	3.06	1.46	0.05
Total Current Liabilities	32.9	16.67	11.84	8.47	4.66	2.34	0.33
Long-Term Debt	93.84	1.11	1.4	1.03	0	0	0
Other Long-Term Liabilities	2.34	0	0	0	0	0	0
Total Long-Term Liabilities	96.18	1.11	1.4	1.03	0	0	0
Total Liabilities	129.08	17.77	13.24	9.5	4.66	2.34	0.33
Total Debt	93.84	1.11	1.4	1.03	0	0.37	0
Debt Growth	8392.04%	-20.96%	35.86%	-	-	-	-
Common Stock	488.32	467.46	345.55	83.58	62.61	3.47	-0.32
Retained Earnings	-411.55	-245.79	-138.86	-56.69	-23.72	-4.45	0
Shareholders' Equity	76.78	221.67	206.7	26.9	38.89	-0.98	-0.32
Net Cash / Debt	99.89	231.86	211.72	31.4	42.57	0.52	0
Net Cash / Debt Growth	-56.92%	9.51%	574.34%	-26.24%	8149.03%	-	-
Net Cash Per Share	3.57	8.79	9.76	1.93	2.92	0.05	-
Working Capital	169.97	220.15	205.22	25.64	38.51	-1.45	-0.33
Book Value Per Share	2.74	8.40	9.53	1.65	2.67	-0.10	-0.03

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).